ACHE and early-onset autosomal dominant Alzheimer disease: Of all the candidates investigated recently, crinine-derivative 11-O-acetyl-9-O-demethylmaritidine (42) and other-type Zephycandidine III (85) are interesting targets for further anti-AChE investigation for Alzheimer’s disease.